Cargando…

Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy

SIMPLE SUMMARY: Urothelial bladder carcinoma entails significant health costs due to the high recurrence rates and poor response to standard cisplatin-based treatment. The glycolytic phenotype is a hallmark of proliferating cancer cells, but research is needed to validate the glycolysis-related prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Afonso, Julieta, Gonçalves, Céline, Costa, Marta, Ferreira, Débora, Santos, Lúcio, Longatto-Filho, Adhemar, Baltazar, Fátima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913750/ https://www.ncbi.nlm.nih.gov/pubmed/36765947 http://dx.doi.org/10.3390/cancers15030982

Ejemplares similares

Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients
por: AFONSO, JULIETA, et al.
Publicado: (2014)

Predictive Biomarkers of Bacillus Calmette-Guérin Immunotherapy Response in Bladder Cancer: Where Are We Now?
por: Lima, Luís, et al.
Publicado: (2012)

A pan-cancer analysis of the role of hexokinase II (HK2) in human tumors
por: Li, Ruiqi, et al.
Publicado: (2022)

Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study
por: GHOLAMI, Shakiba, et al.
Publicado: (2023)

Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44
por: Pinheiro, Céline, et al.
Publicado: (2010)

Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
por: Wang, Huanan, et al.
Publicado: (2016)

Erratum to: Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
por: Wang, Huanan, et al.
Publicado: (2016)

Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors
por: Pinheiro, Céline, et al.
Publicado: (2015)

Exploiting monocarboxylate transporters as new molecular targets for colorectal carcinoma therapy
por: Amorim, Ricardo, et al.
Publicado: (2013)

Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway
por: Liu, Hui, et al.
Publicado: (2017)

Aiding Cancer’s “Sweet Tooth”: Role of Hexokinases in Metabolic Reprogramming
por: Farooq, Zeenat, et al.
Publicado: (2023)

Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
por: Longatto-Filho, Adhemar, et al.
Publicado: (2009)

Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas
por: Pinheiro, Céline, et al.
Publicado: (2015)

FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription
por: Wang, Yu, et al.
Publicado: (2016)

PHLPP regulates hexokinase 2-dependent glucose metabolism in colon cancer cells
por: Xiong, Xiaopeng, et al.
Publicado: (2017)

Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance
por: Lee, Min Young, et al.
Publicado: (2018)

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
por: Scholtes, Mathijs P., et al.
Publicado: (2021)

Conditional Reprogramming Modeling of Bladder Cancer for Clinical Translation
por: Daneshdoust, Danyal, et al.
Publicado: (2023)

A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers
por: Xu, Shili, et al.
Publicado: (2018)

Angiogenesis and Breast Cancer
por: Longatto Filho, Adhemar, et al.
Publicado: (2010)

Hexokinase 2 Is a Pivot for Lovastatin-induced Glycolysis-to-Autophagy Reprogramming in Triple-Negative Breast Cancer Cells
por: Xue, Lian, et al.
Publicado: (2022)

Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
por: Vantaku, Venkatrao, et al.
Publicado: (2017)

Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective
por: Lorenzi, Adriana T., et al.
Publicado: (2015)

Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options
por: Rodrigues, Daniela, et al.
Publicado: (2016)

Predictor Variables and Screening Protocol for Depressive and Anxiety Disorders in Cancer Outpatients
por: Lima, Manuela Polidoro, et al.
Publicado: (2016)

Correction: Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
por: Vantaku, Venkatrao, et al.
Publicado: (2019)

Hexokinase 2 as oncotarget
por: Patra, Krushna C., et al.
Publicado: (2013)

Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2
por: Londhe, Priya, et al.
Publicado: (2018)

The Roles of HK2 on Tumorigenesis of Cervical Cancer
por: Liu, Chunyan, et al.
Publicado: (2019)

Historical Analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: A Time for Reflection
por: Costa, Ricardo Filipe Alves, et al.
Publicado: (2015)

Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells
por: Kudryavtseva, Anna V., et al.
Publicado: (2016)

Targeting hexokinase 2 in castration-resistant prostate cancer
por: Deng, Yibin, et al.
Publicado: (2015)

Downregulation of hexokinase 2 improves radiosensitivity of breast cancer
por: Zhang, Dan, et al.
Publicado: (2019)

The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma
por: Jin, Fangfang, et al.
Publicado: (2017)

Gastric Cancer and Angiogenesis: Is VEGF a Useful Biomarker to Assess Progression and Remission?
por: Macedo, Filipa, et al.
Publicado: (2017)

Human papillomavirus genotyping as a tool for cervical cancer prevention: from commercially available human papillomavirus DNA test to next-generation sequencing
por: Dias, Tauana Christina, et al.
Publicado: (2020)

Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma
por: Vieira de Castro, Joana, et al.
Publicado: (2021)

HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors
por: Martinho, Olga, et al.
Publicado: (2017)

Circular RNA circ_0061140 accelerates hypoxia-induced glycolysis, migration, and invasion in lung adenocarcinoma through the microRNA-653/hexokinase 2 (HK2) axis
por: Wang, Shaobin, et al.
Publicado: (2022)

Targeting lactate transport suppresses in vivo breast tumour growth
por: Morais-Santos, Filipa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_53uo4unp0672o7g49bij71e7d0